CJJ300
CJJ300 is a small molecule TGF-β signaling inhibitor (IC50: 5.3 μM) that acts by disrupting the TGF-β receptor complex formation. This mechanism effectively suppresses downstream signaling, inhibiting cellular processes such as migration in vitro, making it a useful tool for fibrosis, cancer, and developmental biology research.
Product Specifications
CAS Number
1807631-83-9
Product Name Alternative
Smad, TGFb, TGF-β, TGFβ, TGF-β/Smad, TGF-b/Smad, TGFbeta/Smad, TGF-beta, TGFbeta
Field of Research
Stem Cell & Developmental Biology
Purity
99.41% (May vary between batches)
Solubility
DMSO:100 mg/mL (229.57 mM) ;10% DMSO+90% Corn Oil:3.3 mg/mL (7.58 mM)
Smiles
C (NC1=CC=CC=C1) C2=C (C) C (CNC3=CC=CC=C3) =C (C) C (CNC4=CC=CC=C4) =C2C
Molecular Formula
C30H33N3
Molecular Weight
435.6
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS9927862 Inquire
Donkey Von Willebrand Factor A Domain Containing Protein 5A (VWA5A) ELISA Kit
Sign In for Pricing
View Details 
orb2841145 100 µL
Phospho-BHMT1 (Thr45) Rabbit pAb, APC-Cy5.5 conjugated
Sign In for Pricing
View Details 
GTR15115776 1 Vial
Lentiviral human NXPH2 shRNA (UAS) - Lentiviral human NXPH2 shRNA (UAS, RFP) (100)
Sign In for Pricing
View Details